Systemic interleukin profile of elderly patients with cataract combined with senile asthenia syndrome

Immune disorders play an important role in development of age-related ophthalmic diseases (e.g., cataracts, age-related macular degeneration), as well as in geriatric conditions and, above all, in senile asthenia syndrome, the leading deficiency syndrome among people at their older age. However, the changes in systemic interleukins in patients with simultaneous presence of two age-associated conditions (cataract and senile asthenia syndrome) were only poorly studied. The aim of the present work was to evaluate the systemic interleukin profile in elderly patients affected by cataracts combined with senile asthenia syndrome of different severity. Patients and methods: The contents of interleukins in blood serum was analyzed in a clinical setting among patients aged 60 to 74 years for all the groups which manifested with isolated cataracts (n = 58), cataracts and senile preasthenia (n = 49), and cataracts and senile asthenia syndrome (n = 56). The diagnosis of senile asthenia syndrome was established in accordance with indexes of the phenotypic model by Fried L. et al., and cataracts, according to results of clinical ophthalmological examination. Determination of IL-1, IL-1β, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-17 and IL-18 were performed by enzyme immunoassay followed by calculation of relative risk for each of the above interleukin, as generally accepted. Results: A statistically significant increase of IL-1, IL-1β, IL-6, IL-8, IL-13 levels, along with decrease in IL-4, IL-10 were shown in the patients presenting with combination of cataract and senile pre-asthenia, as compared with patients with only cataracts. Among the patients with cataracts and senile asthenia syndrome, the disorders were diagnosed for a large number of interleukins, with increased levels of IL-1, IL-1β, IL-6, IL-8, IL-9, IL-12, IL-13, IL-17, IL-18, and decreased concentrations of IL-4, IL-10, in comparison with cases of isolated cataract, or cataract combined with senile preasthenia. Significant values of relative risk were revealed for cataract and senile preasthenia, i.e., for IL-1 (1.27), IL-1β (1.20), IL-4 (1.21), IL-6 (1.19), IL-8 (1.93), IL-10 (2.15) and IL-13 (1.23), and, in cases of cataracts and senile asthenia syndrome, for IL-1 (1.45), IL-1β (1.31), IL-4 (1.38), IL-6 (1.57), IL-8 (2.86), IL-10 (2.39), IL-13 (1.39), IL-17 ( 1.27). The results obtained point to marked changes in the mentioned systemic interleukins among the patients aged 60 to 74 years, and more pronounced association of these changes with cataract combined with senile asthenia syndrome, than with cataract and senile preasthenia.

1. Agarkov N.M., Gurko T.S., Lev I.V. Changes in the blood complement system in the development of diabetic retinopathy in old age. Nauchnye rezultaty biomeditsinskikh issledovanij = Scientific Results of Biomedical Research, 2021, Vol. 7, no. 2, pp. 173-180. (In Russ.)

2. Ayvazyan S.A., Mkhitaryan V.S. Applied statistics and fundamentals of econometrics. Moscow: UNITY, 2001. 656 p.

3. Balatskaya N.V., Eremeeva E.A., Slepova O.S. Subpopulation composition of peripheral blood lymphocytes in patients with age-related macular degeneration. Meditsinskaya immunologiya = Medical immunology (Russia), 2015, Vol. 17, no. 5, pp. 461-466. (In Russ.) doi: 10.15789/1563-0625-2015-5-461-466.

4. Devyatkin A.A., Egorova E.V. Systemic mechanisms of immunity in patients with senile cataract during immunocorrective therapy. Vestnik Orenburgskogo gosudarstvennogo universiteta = Bulletin of the Orenburg State University, 2004, no. S, pp. 147-149. (In Russ.)

5. Konyaev D.A., Popova E.V., Titov A.A., Agarkov N.M., Yablokov M.M., Aksenov V.V. The prevalence of eye disease in the elderly is a global problem of our time. Zdravoohranenie Rossiyskoy Federatsii = Healthcare of the Russian Federation, 2021, Vol. 65, no. 1, pp. 62-68. (In Russ.)

6. Malishevskaya T.N., Dolgova I.G., Shatskikh S.V. Personalized approach to the management of patients with advanced glaucoma. The choice of strategic directions of anti-glaucoma work in the Tyumen region. Natsionalnyy zhurnal glaucoma = National Journal of Glaucoma, 2016, Vol. 15, no. 4, pp. 42-53. (In Russ.)

7. Namazova I.K., Smailova G.T., Medzhidova S.R., Salmanova A.R. Determination of cytokines in blood serum and in anterior chamber moisture in pseudoexfoliative syndrome and cataract. Uspekhi gerontologii = Advances in Gerontology, 2020, Vol. 33, no. 2, pp. 352-359. (In Russ.)

8. Sozurakova E.A., Gromakina E.V., Shabaldin A.V., Shternis T.A., Sedova D.Yu., Tretyak E.A., Shingareva S.O. Assessment of the role of immunoregulatory potential in limiting local inflammation in the anterior chamber of the eye (on the example of presenial cataract). Sovremennye problemy nauki i obrazovaniya = Modern Problems of Science and Education, 2019, no. 2, p. 129. (In Russ.)

9. Chukaeva I.I., Larina V.N. Ageassociated conditions (geriatric syndromes) in the practice of a polyclinic therapist. Lechebnoe delo = Medicine, 2017, no. 1, pp. 6-15. (In Russ.)

10. Chukhraev A.M., Agarkov N.M., Proschaev K.I., Ilnitsky A.N. Features of the local interleukin status of elderly patients with primary angle-closure glaucoma. Oftalmologiya = Ophthalmology, 2021, Vol. 18, no. 1, pp. 123-128. (In Russ.)

11. Chen X., Shi S., Zhu L., Gu N. IL-6 and TNF-α induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J. Interferon Cytokine Res., 2014, Vol. 34, no. 5, pp. 342-348.

12. Fried L.P., Carlson M.C., Freedman M., Frik K.D., Glass T.A., Hill J., McGill S., Rebok G.W., Seerman T., Tielsch J., Wasik B.A., Zeger S. A social model for health promotion for an aging population: initial evidence on the Experience Corps model. J. Urban Health, 2004, Vol. 841, no. 1, pp. 64-78.

13. Juarez-Cedillo T., Vargas-Alarcon G., Martinez-Rodriguez N., Juarez-Cedillo E., Fragoso J.M., Escobedode-la-Pena J. Interleukin 10 gene polymorphisms and frailty syndrome in elderly Mexican people: (Sadem study). Mol. Genet. Genom.Med., 2019, Vol. 7, no. 9, e918. doi: 10.1002/mgg3.918.

14. Junior G.S., Perez D.I., Tonet-Furioso A.C., Gomes L., Vilaca K.H., Alves V.P., Moraes C.F., Nobrega O.T. Circulating Interleukin-6 (but not other immune mediators) associates with criteria for Fried’s frailty among very old adults. J Aging Res., 2020, Vol. 2020, 6831791. doi: 10.1155/2020/6831791.

15. Junior G.S., Souza V.C., Machado-Silva W., Henriques A.D., Avelar G.G., Perez D.I., Lima R.M., Silva R.J., Brito C.J., Nobrega O.T. Resistance training modulates the humoral inflammatory (but not the DNA methylation) profile of diabetic older adults using metformin. Neuroimmunomodulation, 2019, Vol. 26, pp. 1-8.

16. Liu C.K., Lyass A, Larson M.G., Massaro J.M., Wang N., D’Agostino R.B., Benjamin E.J., Murabito J.M. Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study. Age (Dordr.), 2016, Vol. 38, no. 1, 1. doi: 10.1007/s11357-015-9864-z.

17. Morley J.E., Vellas B., Kan G.A., Anker S.D., Bauer J.M., Bernabei R., Cesari M., Chumlea W.C., Doehner W., Evans J., Fried L.P., Guralnik J.M., Katz P.R., Malmstrom T.K., McCarter R.J., Robledo L.M., Rockwood K., Haehling S., Vandewoude M.F., Walston J. Frailty consensus: a call to action. J. Am. Med. Dir. Assoc., 2013, Vol. 14, no. 6, pp. 392-397.

18. Nascimento C.M., Zazzetta M.S., Gomes G.A., Orlandi F.S., Gramani-Say K., Vasilceac F.A., Gratao A.C., Pavarini S.C., Cominetti M.R. Higher levels of tumor necrosis factor beta are associated with frailty in socially vulnerable community-dwelling older adults. BMC Geriatr., 2018, Vol. 18, no. 1, 268. doi: 10.1186/s12877-018-0961-6.

19. Pawelec G., Bronikowski A., Cunnane S.C., Ferrucci L., Franceschi C., Fulop T., Gaudreau P., Gladyshev V.N., Gonos E.S., Gorbunova V., Kennedy B.K., Larbi A., Lemaitre J., Liu G., Maier A.B., Morais J.A., Nobrega O.T., Moskalev A., Rikkert M.O., Seluanov A., Senior A.M., Ukraintseva S., Vanhaelen Q., Witkowski J., Cohen A.A. The conundrum of human immune system “senescence”. Mech. Ageing Dev., 2020, Vol. 192, 111357. doi: 10.1016/j.mad.2020.111357.

20. Pivetta N.R., Marincolo J.C., Neri A.L., Aprahamian I., Yassuda M.S., Borim F.S. Multimorbidity, frailty and functional disability in octogenarians: a structural equation analysis of relationship. Arch. Gerontol. Geriatr., 2019, Vol. 86, 103931. doi: 10.1016/j.archger.2019.103931

21. Ou T., Yang H., Walston J.D., Fedarko N.S., Leng S.X. Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine, 2009, Vol. 46, pp. 319-324.

22. Soysal P., Stubbs B., Lucato P., Luchini C., Solmi M., Peluso R., Sergi G., Isik A.T., Manzato E., Maggi S., Maggio M., Prina A.M., Cosco T.D., Wu Y., Veronese N. Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res. Rev., 2016, Vol. 31, pp. 1-8.

23. Vetrano D.L., Palmer K.M., Galluzzo L., Giampaoli S., Marengoli A., Bernabei R., Onder G. Hypertension and frailty: a systematic review and meta-analysis. BMJ Open, 2018, Vol. 8, Iss. 12, e024406. doi: 10.1136/bmjopen-2018-024406.

24. Yarla N.S., Polito A., Peluso I. Effects of olive oil on TNF-alpha and IL-6 in humans: implication in obesity and frailty. Endocr. Metab. Immune Disord. Drug Targets, 2018, Vol. 18, no. 1, pp. 63-74.

25. Zuo Z., Li J., Ge S., Shen M., Wang Y., Zhou C., Wu R., Hu J. Bryostatin-1 ameliorated experimental colitis in in Il-10 -/- Mice by protecting the intestinal barrier and limiting immune dysfunction. J. Cell. Mol. Med., 2019, Vol. 23, no. 8, pp. 5588-5599.